Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;26(7):2144-2153.
doi: 10.1245/s10434-019-07159-4. Epub 2019 Feb 13.

Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis

Sarah B Bateni  1 , Anders J Davidson  1 , Mili Arora  2 , Megan E Daly  3 , Susan L Stewart  4 , Richard J Bold  1   5 , Robert J Canter  1   5 , Candice A M Sauder  6   7
Affiliations

Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis

Sarah B Bateni et al. Ann Surg Oncol. 2019 Jul.

Abstract

Background: Current treatment guidelines for male breast cancer are predominantly guided by female-only clinical trials. With scarce research, it is unclear whether breast-conserving therapy (BCT) is equivalent to mastectomy in men. We sought to compare overall survival (OS) among male breast cancer patients who underwent BCT versus mastectomy.

Methods: We performed a retrospective analysis of 8445 stage I-II (T1-2 N0-1 M0) male breast cancer patients from the National Cancer Database (2004-2014). Patients were grouped according to surgical and radiation therapy (RT). BCT was defined as partial mastectomy followed by RT. Multivariable and inverse probability of treatment-weighted (IPTW) Cox proportional hazards models were used to compare OS between treatment groups, controlling for demographic and clinicopathologic characteristics.

Results: Most patients underwent total mastectomy (61.2%), whereas 18.2% underwent BCT, 12.4% underwent total mastectomy with RT, and 8.2% underwent partial mastectomy alone. In multivariable and IPTW models, partial mastectomy alone, total mastectomy alone, and total mastectomy with RT were associated with worse OS compared with BCT (p < 0.001 all). Ten-year OS was 73.8% for BCT and 56.3, 58.0 and 56.3% for other treatment approaches. Older age, higher T/N stage, histological grade, and triple-negative receptor status were associated with poorer OS (p < 0.05). Subgroup analysis by stage demonstrated similar results.

Conclusions: In this national sample of male breast cancer patients, BCT was associated with greater survival. The underlying mechanisms of this association warrant further study, because more routine adoption of BCT in male breast cancer appears to translate into clinically meaningful improvements in survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Figures

Figure 1.
Figure 1.
A-B. Crude (A) and inverse probability of treatment weighted (B) overall survival for male breast cancer patients with breast conserving therapy (BCT), total mastectomy with (TM with RT) and without radiation therapy (TM no RT), and partial mastectomy alone (PM no RT).
Figure 2.
Figure 2.
A-B. Univariate overall survival for breast conserving therapy (BCT) compared to partial mastectomy alone (PM no RT), total mastectomy alone (TM no RT) and total mastectomy with radiation therapy (TM with RT) by stage.
Figure 3.
Figure 3.
A-B. Univariate overall survival for breast conserving therapy (BCT) compared to partial mastectomy alone (PM no RT), total mastectomy alone (TM no RT) and total mastectomy with radiation therapy (TM with RT) by T stage.
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin January 2017;67(1):7–30. - PubMed
    1. Gradishar WJ, Anderson BO, Balassanian R, et al. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Version 22017. https://www.nccn.org/professionals/physiciangls/pdf/breast.pdf.
    1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med October 17 2002;347(16):1233–1241. - PubMed
    1. Aggarwal A, Liu ML, Krasnow SH. Breast cancer in male veteran population: an analysis from VA cancer registry. J Community Support Oncol August 2014;12(8):293–297. - PubMed
    1. O’Malley CD, Prehn AW, Shema SJ, Glaser SL. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer June 1 2002;94(11):2836–2843. - PubMed